Home › Prostate Cancer › NCT06039085

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

Microendoscopic Electrical Impedance Sensing for Real-time Intraoperative Surgical Margin Assessment

Who can join

Ages 18 and older · Men

Inclusion Criteria:

1. Clinical diagnosis of prostate cancer requiring RARP.
2. Ability to understand and the willingness to sign a written informed consent document.
3. Age ≥ 18 years old

Exclusion Criteria:

1. Adults with implanted electrical devices such as pacemakers
2. Prisoners
3. Adults with impaired decision-making capacity
4. Any condition for which, in the opinion of the investigator, contraindicates study participation.

About the study

This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.

What is being tested

• custom device to demonstrate a significant difference in electrical impedance signatures (device)

Sponsor: Ryan J. Halter · Participants: 200 · Started: Nov 3, 2023

Contact the study team

• Ryan J Halter, PhD · Phone: (603) 646-0773
• Kathy J Phipps, BA · Phone: 603 646-5793

Official record on ClinicalTrials.gov — NCT06039085

Locations in the U.S.

Conditions

• Prostate Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.